chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Several days after 1st Covid-19 vaccine I have incidents at least 2 times per day feeling shakiness, feeling like blood sugar was low, feeling weak and dizzy and clammy This lasted for 2 weeks post the 1st vaccine. Also experienced headache for 10 days post vaccine. After dose 2, Flushing on face and chest. Tingling and heaviness on chest. Feeling short of breath and feeling tightness in throat Tingling of arms. BP was 141/101 (normally runs low). I was informed that I was having a panic attack and was released by the staff. Chest tightness, heaviness and difficulty breathing continued. On Saturday 2/13 I went to urgent care and was prescribed an inhaler and steroids for shortness of breath. I continue with feeling heaviness in my chest, difficulty with shortness of breath, and hoarseness in my voice/tightness in my throat especially with increased activity or talking.
Itching skin with no apparent cause Raised red welts with even a slight scratch Controlled by Zyrtec, but appears again once Zyrtec wears off every night
Large reddened area that appeared to be cellulitis 10x12 cm area on right thigh.
Dizziness, HYPERtension & Tachycardia Narrative: 5 min after vaccine administered L arm felt dizzy. 170/100, HR 133, 97% RA at 1220. Reported poor sleep and mild anxiety. 115/76, HR 116, 96% RA at 1234. At 1237 denies any dizziness or other adverse effects.
Patient inadvertently given 0.15 mL dose instead of required/recommended 0.3 mL dose. CDC contacted and advised to have patient return ASAP to receive correct dose. No adverse affects reported per patient. Patient returned for repeat of COVID19 (Pfizer-BioNTech) dose #2 on 10/5/2021.
This case was reported by a consumer via interactive digital media and described the occurrence of cough in a adult female patient who received DTPa (Reduced antigen) (dTpa vaccine). In 2014, the patient received dTpa vaccine. On an unknown date, an unknown time after receiving dTpa vaccine, the patient experienced cough. On an unknown date, the outcome of the cough was unknown. It was unknown if the reporter considered the cough to be related to dTpa vaccine. Additional details were received as follows: The patient received a dose of dTpa vaccine (whooping cough, tetanus, and diphtheria) vaccine a year ago, because she was going to be a grandparent. The patient stated that she was experiencing cough since last year.
Light headed, dizziness, pain in left arm from shoulder to elbow,  fluzzy and numb feeling on roof of mouth, sob, constricted throat,  altered sense of taste.   Episode lasted for about 30 minutes. I sat and rested, focusing on my breathing and not panicking.   I did not seek medical attention.
per death certificate, pt died at home with causes of death being COVID 19 virus and COPD; had a positive COVID test on 1/1/22; DNR; transitioned to comfort measures
About 6 p.m. the night of the shot I started getting tired and weak and really groggy and continued through Sunday by Monday morning I couldn't hardly stand I was dizzy every time I stood up I go blind and almost pass out my husband help me to the bathroom where I could not hold my head or talk or anything my body just kind of convulsed my husband called the ambulance my blood pressure bottom number was 40 and extremely low the ambulance suggested taking me to the hospital I was admitted to the hospital blood pressure bottom number was 40 they pumped a bunch of Iv in me and kept me for the night I was diagnosed with hypotension and near syncope, and neutrophilic leukocytosis adverse reaction to Covid 19 vaccine
48hr p/inj arm sore & red w/diameter 1" lasted for 2 days;
soreness in his hips and back - more sore than usual; soreness in his hips and back - more sore than usual; got rather tired; had a pretty good headache; dizziness when getting up too quickly; heart palpitations; This is a spontaneous report from a contactable consumer (patient himself) via a Pfizer-sponsored program. A male patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; batch/lot number and expiration date were unknown), via an unspecified route of administration on 17Jan2021 at 10:30 at a single dose for COVID-19 immunisation. Relevant medical history included usual soreness in his hips and back. The patient's concomitant medications were not reported. The patient reported he had a few little side effects and that was fine; he was over it at the time of the report. When the injection was given, it was cold going in. There were no side effects for the first 3-4 hours (hrs) after vaccine on 17Jan2021, then after that he got rather tired; in 12 hours, he had a pretty good headache, dizziness when getting up too quickly, and a couple times he did have heart palpitations. On 18Jan2021, the next morning from shot (less than 24 hour after shot), he had soreness in his hips and back, which was more sore than usual. The patient said that by the end of 36 hours, the symptoms resolved. The patient stated he was "48 hours out and he was feeling fine; he might even feel a little better than when he started this whole thing." The patient also stated that the vaccination provider gave him an option for his 2nd dose appointment (days 18-22 post 1st dose). The patient took the earliest appointment, but was wondering at the time of the report, if that would be 'okay' to get the 2nd dose on day 18 or should he call and reschedule for day 21. The patient further reported that he had a Pfizer vaccine shot on Sunday and had a small amount of side effects, but there was no big deal and no problem. They scheduled him for the second shot only 18 days rather than 3 weeks and wanted to check and see if that was something that's ok or that's too close. The patient recovered from all the events on 18Jan2021.  Information on the batch/lot number has been requested.
Within 30 minutes of getting the flu vacine my husband experienced a minor stroke.  After 2 days in the hospital and numerous tests, no other health condition could be found that would indicated why he had a stroke.  We were told it was probably due to the vacine.  He will now be on medication probably the rest of his life becasue since he has had a stroke there is a higher risk he will have another.  At this point, most mobility has returned he still has problem writing.  12/21/07 Reviewed hospital medical records which reveal patient experienced right sided weakness, right mouth drooping, slurred speech x 2 days.  MRI done as outpatient revealed very mild acute stroke.  By hospital admission, functions had returned to 95% normal w/residual slurred speech & very minor weakness of right arm & leg.  Had bump on right deltoid where received flu vax. Admitted 12/5-12/6/2007.  Neuro consult done.  Tx w/anticoagulant.  D/C to home on continued anticoagulant. FINAL DX: none provided.  Neuro consult states pontine stroke.
I received the vaccine I was fine on Friday.  He got up on Saturday and I was very wobbly.  I had a hard time urinating.  I just did not feel like myself.  I had brain fog.  I also had a 99.9 temperature.  By the end of the day my temperature was down, and I still did not feel right.  The next morning, I woke up and felt fine.  I never had pain in my arm from the injection.
Mother reports that approximately 36 hours after the vaccine, patient had an abnormal respiratory pattern (parting respirations & periods of tachypnea), was very pale, & "seemed dazed". No frank lovert seizure activity. Patient was back to normal the next morning.
There were no adverse events/outcomes. A early dose of Polio was given too soon. Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine (Kinrix) was given to the patient instead of the suggested immunization Infanrix. No reported adverse effects
After the first shot was administered, left shoulder/deltoid had pain when raising up or leaning back. Pain intensified after 2nd shot.
Shortly after being vaccinated patient started vomiting. Staff was able to help her and stop vomiting. Later she started vomiting again. Vomit was black and was also passing black stool. This was reported by director of FACILITY.
She received her vaccine, and the first few days had no reaction.  She then noticed itching, redness and swelling yesterday at the site of the vaccine 3/16/21.  She put ice on it and it and it's better today, still warm to touch and swollen but not as bad as yesterday.
Information has been received from a consumer concerning her friend's daughter who was vaccinated with a dose of Gardasil vaccine. The caller wanted to report an adverse event on Gardasil vaccine. No further information was provided. It was unknown if the patient sought medical attention. The outcome was unknown. Additional information has been requested.
The patient had 2nd COVID vaccine and within 15 minutes reported nausea, vision "blacking in and out", heart racing, heavy breathing.  Observed in vaccine clinic observation area for about 15 more minutes - placed patient on a cot, offered cold water and a snack (she had not eaten that morning) and she stated she could not eat. Symptoms did not improve, so she was moved to the ED.  In the ED she reported a headache to front and back of head, weakness, lightheaded and dizziness, and palpitations.  VS in the ED on arrival:  T 99.0, P 87, RR: 87, BP:  120/72, Sp02:  100% on RA.   Treatment in the ED included a 1 liter IV bolus of normal saline @ 1038, 1 IV dose of Zofran 4 mg @ 1038, and 1 PO dose of Tylenol 975mg  @ 1218.    Was discharged in 12:48 PM with the following VS:  T: 99.0, P:  82, RR: 18, BP: 119/77, and Sp02: 100% on RA with continued headache rated a 10 on 0-10 scale, but ambulatory in stable condition.
Patient received vaccine at 36 w gestation EDD 11/28/2023. within 24 h after vaccine developed nausea and erythema to left arm at injection site persisting 48h after vaccination, without history of reactions to different historical vaccinations.
feelings of impending doom (similar to someone having a heart attack); Anxiety, feelings of impending doom (similar to someone having a heart attack); flu like symptoms; vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of ANXIETY (Anxiety, feelings of impending doom (similar to someone having a heart attack)), FEELING ABNORMAL (feelings of impending doom (similar to someone having a heart attack)), VACCINATION SITE PAIN (vaccination site pain) and INFLUENZA LIKE ILLNESS (flu like symptoms) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, the patient experienced VACCINATION SITE PAIN (vaccination site pain). On 08-Apr-2021, the patient experienced ANXIETY (Anxiety, feelings of impending doom (similar to someone having a heart attack)) and INFLUENZA LIKE ILLNESS (flu like symptoms). On an unknown date, the patient experienced FEELING ABNORMAL (feelings of impending doom (similar to someone having a heart attack)). At the time of the report, ANXIETY (Anxiety, feelings of impending doom (similar to someone having a heart attack)), FEELING ABNORMAL (feelings of impending doom (similar to someone having a heart attack)), VACCINATION SITE PAIN (vaccination site pain) and INFLUENZA LIKE ILLNESS (flu like symptoms) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
A spontaneous report was received from a consumer concerning a 74-year-old, female patient who experienced diarrhea and a little sore at injection site/vaccination site pain.   The patient's medical history and concomitant medications were not provided.  On 21-Jan-2021, approximately one day prior to the onset of the symptoms, the patient received their planned first dose of mRNA-1273 injection (Lot/Batch number: 032L20A) intramuscularly for prophylaxis of COVID-19 infection to the upper left arm.   On 22-Jan-2021, the day after injection, the patient was a little sore at the injection site and experienced diarrhea. The soreness at the injection site lasted four to five days and stopped on 27-Jan-2021. The diarrhea persisted until  27JAN2021.  It had been 18 days since she first experienced diarrhea.  She took loperamide hydrochloride and electrolytes NOS/glucose, but had recently stopped. She was not taking any other medications. On 03-Feb-2021, she was seen by her Gastroenterologist, who sent a fecal sample for testing. The test showed no viral infection. She visited her General Practitioner on 08-Feb-2021 for bloodwork. A colonoscopy is planned at some point soon to rule out colitis.   Action taken with mRNA-1273 in response to the events was not provided.  The outcome for the event of diarrhea is not recovered/not resolved. The outcome for the event little sore at injection site is recovered.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
No additional adverse events; a patient was administered a properly stored but expired VAQTA; This spontaneous report was received from a medical assistant and refers to a 25-year-old patient of an unknown gender. There was no information about the patient's concurrent condition, concomitant medication and medical history provided. The report refers to one patient and one combination product.  On 04-JUN-2020, the patient was vaccinated with a dose of hepatitis a vaccine, inactivated (VAQTA) lot number: S001832, expiration date: 12-MAY-2020 for prophylaxis (exact dose and route of administration were not provided). The hepatitis a vaccine, inactivated (VAQTA) was properly stored but expired. No additional adverse events were provided. combinationproductreport: Yes; brandname: VAQTA SYRINGE (DEVICE); commondevicename: Hepatitis A Vaccine, Inactivated; productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp. ; devicelotnumber: S001832; expirationdate: 12-MAY-2020; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Unknown; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
The patient was vaccinated 11/08/2000. Concomitant medication included Synthroid, estrogen and Prevacid. Subsequent to the vaccine, the woman developed pain at the injection site that keeps her awake. No additional information was available as of the date of this report.
Elevated temperature over 101F with chills. Seen by school nurse in family home on 10/13/2006 with temperature less than 100F. Nurse recommended that child be seen by physician if no improvement by 10/14/2006.
All are currently ongoing: Pain, redness, and swelling at the injection site Muscle pain Tiredness Headache Shivering Upset stomach Warm but not running a fever
Immz given on 03/29/2005 PM. Mother noticed redness and swelling on 3/30/05 early PM. Lasted x 24 hrs. Now has resolved.
My symptoms  started on 06/09/2022 at around 7:00pm in the evening. I  had a sore throat;  and fatigue. On the 06/10/2022 I did a tele health with a doctor from pharmacy regarding my COVID-19 symptoms. She prescribed Lagevrio; Benzoate;  and Albuterol. The first medication I took it for 5 days.  The other 2 medications I took it as needed even thought I took it only once.
something with the needle or barrel was wrong so a good portion of the dose sprayed back at me with no AE; something with the needle or barrel was wrong so a good portion of the dose sprayed back at me with no AE; Initial information received on 21-Oct-2019 regarding an unsolicited valid non-serious case received from a pharmacist.  This case is linked to case 2019SA293075 (for patient).  This case involved a female patient (administering pharmacist) for whom it was reported that something with the needle or barrel was wrong (Syringe issue), a good portion of the dose sprayed back at Pharmacist (Occupational exposure to product and needle issue) and were reported, while she was administering vaccine INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (FLUZONE HIGH DOSE) to the patient.  Medical history, treatment, past vaccinations and concomitant medication were not reported.  On 18-Oct-2019, the patient was administering a dose of suspect INFLUENZA USP TRIVAL A-B HIGH DOSE SUBVIRION VACCINE (Lot number- UJ285AB) via intramuscular route in the right arm .  It was a case of actual medication error due to Occupational exposure to product and needle issue.  It was reported that something with the needle or barrel was wrong so a good portion of the dose sprayed back at me and dribbled down the patient's arm. The patient is fine, but most of the dose was lost through the end of the plunger. The Pharmacist reported that a consumer did not receive their full dose of Fluzone High-Dose due to the vaccine sprayed from the end of the plunger.  At the time of report no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Patient was administered VARIVAX while she was 17 weeks gestation; This spontaneous report was received from a physician concerning a female patient who was currently 26 years old. The patient historical conditions included anxiety and pyelonephritis, the patient reported that was allergic to latex. Information regarding the patient's historical drug was not provided.   Concomitant therapies included acetylsalicylic acid (BABY ASPIRIN)  On an unspecified date, the patient was vaccinated with varicella virus vaccine live (Oka/Merck) (VARIVAX) (dosage regimen, route of administration, lot number and expiration date were not provided) for prophylaxis.  The patient was pregnant at the time of vaccination. During a 20 week prenatal appointment, the patient informed the HCP what occurred. Initial exposure to varicella virus vaccine live (oka/merck)(VARIVAX) was at 17 week(s). The LMP and EDD was not reported. The pregnancy outcome was pending.   The patient was enrolled in the Varicella Zoster Virus Identification Program to identify if VZV is present and if it is present, to identify if it is associated with the wild-type (WT) VZV strain or with the Oka/Merck vaccine strain. However, information arrived incomplete. It was only reported that the patient had not been exposed or presented chickenpox or shingles.
Left arm very sore I couldn't even lift it. My teeth hurt for days.  3 months later after swimming a mile I found the next day that y left arm hurt badly and my teeth hurt for several days. These symptoms come and go
Initial unsolicited report received from a consumer via social media on 10 Oct 2016. This case is linked with 2016SA188144, 2016SA188556, 2016SA188803, 2016SA188804, 2016SA188805, 2016SA188806, 2016SA188807, 2016SA188808, 2016SA188809, 2016SA188810, 2016SA188811, 2016SA188812, 2016SA188814, 2016SA188815, 2016SA188816, 2016SA188817, 2016SA188818, 2016SA188819, 2016SA188820, 2016SA188821, 2016SA188822, 2016SA188833, 2016SA188834, 2016SA188835, 2016SA188836, 2016SA188837, 2016SA188838, 2016SA188839, 2016SA188840, 2016SA188841, 2016SA188842, 2016SA188843, 2016SA188844, 2016SA188845, 2016SA188846, 2016SA188847, 2016SA188848, 2016SA188849, 2016SA188850, 2016SA188851 (same source, same vaccine). This case involves a patient (age and gender was not reported) who was vaccinated with a dose of Flu Shot (batch number, expiry date, dose, dose in series, route and site of administration were not reported) on an unknown date. The medical history and concomitant medications were not reported. On an unknown date, 2 weeks following the vaccination, the patient was just about died with the flu. The laboratory data and corrective treatment was not reported. The outcome of event was not reported. List of documents held by sender: none.
Initial report received on 17/Aug/2006 from a health care professional.  A female patient (date of birth not reported) with no current illnesses had received a fifth intramuscular dose of Tripedia, lot number U16158A, in the left deltoid, and a fourth subcutaneous dose of IPOL, lot number, Y0991, in the left arm, on 07/Aug/2006 at 11:00 am.  Ten hours post-immunization, the patient experienced some upper arm swelling.  The next day, the swelling in the upper arm had increased, and the patient had erythema that was almost completely around the humerus bone, and she had pain.  The patient had not been evaluated by a physician at the time of the report.  Treatment received was not reported.  The recovery status of the patient was reported as recovered.  The reporter for this case is the same as for case 2006-02197.
Pt states that starting the next morning after receiving her vaccines, the injection site became swollen, red, itchy, tender, and warm to the touch. Over the next few days the reaction began to spread out from the injection site and formed a large red band all the way around her upper left arm. Pt presented to the pharmacy to determine what she should do. Pharmacist recommended OTC BENADRYL and a visit to her PCP, since pt reported a history of adverse reaction to a tetanus vaccine.
pt recvd vax; rt thigh red, swollen & a knot in it;got d,v,fever & fussy;to M who said common rxn,nothing to worry about;
Arm extremely sore; Eyes sensitive to light; Arm extremely sore including her armpit; Chills; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Arm extremely sore), PHOTOSENSITIVITY REACTION (Eyes sensitive to light), AXILLARY PAIN (Arm extremely sore including her armpit) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by reporter.  No concomitant medication reported.     On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm extremely sore), PHOTOSENSITIVITY REACTION (Eyes sensitive to light), AXILLARY PAIN (Arm extremely sore including her armpit) and CHILLS (Chills). At the time of the report, PAIN IN EXTREMITY (Arm extremely sore), PHOTOSENSITIVITY REACTION (Eyes sensitive to light), AXILLARY PAIN (Arm extremely sore including her armpit) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment medication was not provided.
24hrs p/vax pt began gen pruritus;seen 48hrs following vax more severe pruritus, skin erythema w/o dysphagia
pt recv vax 18SEP96 & devel kawasaki disease on 25SEP96;pt hosp on 27SEP97 & discharged on 30SEP96;pt recovered;